Our experiments uncovered that differentiated ERMS cells seed new areas of growth, followed later by slow-moving, less-differentiated myf5+ TPCs, challenging the notion that cancer stem cells drive invasion and metastasis. The gene discussed is MYF5; the disease is cancer.